Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0EM6S
|
|||
| Former ID |
DIB009718
|
|||
| Drug Name |
Recombinant viral vector vaccine
|
|||
| Synonyms |
Ebola virus vaccine, AlphaVax; Filovirus vaccine, AlphaVax; Marburg virus vaccine, AlphaVax; Recombinant viral vector vaccine (ArV, VEE virus technology, filovirus/Marburg/Ebola virus infection); Recombinant viral vector vaccine (ArV, VEE virus technology, filovirus/Marburg/Ebola virus infection), AlphaVax
Click to Show/Hide
|
|||
| Indication | Ebola virus infection [ICD-11: 1D60.0] | Phase 1 | [1] | |
| Company |
GenPhar; Crucell; Vaccine Research Center (NIAID)
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020010) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.